Background illustration for clinical trials search

Paid Clinical Trials Corpus Christi

Discover 61 paid clinical trials in Corpus Christi, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 61

Featured

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

for

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis,

Location: Corpus Christi TX, Edinburg TX, San Antonio TX,

Sponsor: 89bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06318169

Phase3, Recruiting

Featured

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

for

Obesity or Overweight

Location: Corpus Christi TX, McAllen TX, San Antonio TX,

Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07351045

Phase3, Recruiting

Active & Responsive

A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight

for

Overweight or Obesity and Elevated Liver Fat

Location: Corpus Christi TX, Edinburg TX, Pharr TX,

Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07441252

Phase2, Recruiting

Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for

NASH With Fibrosis, MASH With Fibrosis

Location: Corpus Christi TX, McAllen TX, Edinburg TX,

Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase3, Recruiting

Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for

NASH - Nonalcoholic Steatohepatitis,

Location: Corpus Christi TX, Edinburg TX, San Antonio TX,

Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase3, Recruiting

Active & Responsive

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

for

Coronavirus Disease (COVID-19)

Location: Corpus Christi TX, Victoria TX, Laredo TX, Pearland TX,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06667700

Phase3, Recruiting

Active & Responsive

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

for

Obesity, Heart Failure

Location: Corpus Christi TX, McAllen TX, San Antonio TX,

Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07567001

Phase3, Recruiting

Active & Responsive

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

for

Sjögren´s Disease

Location: Corpus Christi TX, Bellaire TX, Houston TX,

Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07621809

Phase3, Recruiting

Droperidol and QTc Interval Changes in ED Patients

for

Emergency Department Patient, QTc Intervals Changes

Location: Corpus Christi TX

Sponsor: CHRISTUS Health

Sex: All

Age: 18+

Code: NCT06726811

Recruiting

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for

Breast Cancer

Location: Corpus Christi TX, San Antonio TX, Sugar Land TX,

Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting

Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.

for

Diabetic Foot Ulcer, Type 1 Diabetes Mellitus,

Location: Corpus Christi TX

Sponsor: Estar Medical dba Medical Technologies, LTD

Sex: All

Age: 18 - 70+

Code: NCT06810726

Phase2, Recruiting

A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)

for

MASH - Metabolic Dysfunction-Associated Steatohepatitis

Location: Corpus Christi TX, San Antonio TX, Sugar Land TX,

Sponsor: Rivus Pharmaceuticals, Inc.

Sex: All

Age: 30+

Code: NCT07491458

Phase2, Recruiting

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

for

Metabolic Dysfunction Associated Steatohepatitis (MASH),

Location: Corpus Christi TX, Edinburg TX, McAllen TX,

Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06632444

Phase3, Recruiting

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age

for

Chickenpox

Location: Corpus Christi TX, McAllen TX, Houston TX, Beaumont TX,

Sponsor: GlaxoSmithKline

Sex: All

Age: 1

Code: NCT06740630

Phase3, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for

Cardiovascular Disease

Location: Corpus Christi TX, Victoria TX, Pharr TX, McAllen TX,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase3, Recruiting

New

PULSE - Patient Understanding and Learning Through Structured Education - Effectiveness and Implementation of Patient Education Videos in a New Pediatric Cardiology Clinic

for

Cardiology, Pediatric Cardiac Surgery, Education,

Location: San Antonio TX

Sponsor: Driscoll Children's Hospital

Sex: All

Age: 0 - 18

Code: NCT07594041

Recruiting

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

for

Basal Ganglia Germinoma, Diabetes Insipidus, Germinoma,

Location: Corpus Christi TX, San Antonio TX, Austin TX,

Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT06368817

Phase2, Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for

Stage I Mixed Cell Type Kidney Wilms Tumor,

Location: Corpus Christi TX, San Antonio TX, Austin TX,

Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase3, Recruiting

Impact of Early Fortini Initiation on Growth and Interstage Outcomes in Infants With Single Ventricle Physiology

for

Single-ventricle

Location: Corpus Christi TX

Sponsor: Driscoll Children's Hospital

Sex: All

Age: 0

Code: NCT07087782

Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for

Rhabdomyosarcoma

Location: Corpus Christi TX, San Antonio TX, Austin TX, Dallas TX,

Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase3, Recruiting

Paid Clinical Trials Corpus Christi

Filter results

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Interested in new trials?

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

Droperidol and QTc Interval Changes in ED Patients

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.

A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

PULSE - Patient Understanding and Learning Through Structured Education - Effectiveness and Implementation of Patient Education Videos in a New Pediatric Cardiology Clinic

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

Impact of Early Fortini Initiation on Growth and Interstage Outcomes in Infants With Single Ventricle Physiology

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)